The following guideline can be ordered through the address listed in the "Source/Publisher"-category. In cases in which you can order through the Internet we have established a hyperlink.

Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities

Short Title:
EMA/CHMP/ CVMP/ SWP/169430/2012
Origin/Publisher:

European Commission, Enterprise and Industry; http://ec.europa.eu/enterprise/

Document Type:
Guideline
Content:
When different medicinal products are produced in shared facilities, the potential for cross-contamination is a concern. Medicinal products provide a benefit to the intended patient or target animal; however as a cross contaminant, they provide no benefit to the patient or target animal and may even pose a risk.

Go back

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK